Donald Trump downgrades cannabis via executive order, prompting some to wonder if weed is a schedule 3 drug now, and ...

Local police and DEA agents recently ended a months-long investigation into a large-scale Indy drug dealing operation, ...

From health and crime to education, we take a look at some of the biggest stories that touched, surprised or shook ...

Federal regulatory changes, including Trump's executive order, are unlikely to materially impact cash flows for most major ...

A roundtable on what’s holding back the local cannabis industry and another three-year waiver of lab testing requirements are ...

Less than 30% of people with certain genetic variants go blind, despite the faulty genes previously being thought to cause ...

In this opinion piece, Field to Market President Carrie Vollmer-Sanders welcomes the Trump administration's regenerate ag ...

In a rapidly evolving industry, the coming year stands to hold both challenges and meaningful progress for law firms, ...

MIAMI, FLORIDA / ACCESS Newswire / December 19, 2025 / Remergify, the preeminent leader in corporate resurrection and asset revitalization for dormant and undervalued public companies, today announced ...

From this chilly vantage point, Villareal can see his monitor and also the top half of 270 Park Avenue, the new JPMorgan ...

President Trump’s move to reclassify marijuana from a “Schedule I” to “Schedule III” drug stops short of full legalization.

A global shortage fed by a big uptake by Gen Z has pushed the price of 100 grams of matcha from $26 to $46 within a year. If ...